How Thermo Fisher Scientific built AI-powered patient matching on AWS

Thermo Fisher Scientific deployed a cloud-based clinical trial recruitment architecture on Amazon Web Services to modernize how recruitment teams identify patient cohorts and track trial performance. The platform unifies fragmented clinical records across trials, sites, and marketing funnels into curated datasets designed for self-service analysis. According to AWS Architecture Blog's report, the deployment combines a centralized analytics interface named Central Insights Hub with a proprietary natural-language cohort discovery tool known as Patient Match AI.

This report details how the life sciences company unified disconnected clinical datasets, deployed self-service cohort search tools, and structured its cloud analytics pipeline. Clinical trial sponsors, enterprise data architects, and healthcare operations leads can use this breakdown to evaluate recruitment data patterns and production launch practices. The system replaces weeks of manual technical queries with self-service analytics while maintaining regulatory safeguards for sensitive patient identities and consent boundaries.

01Disconnected records and manual database queries

Clinical trial recruitment historically required teams to navigate disconnected records distributed across multiple legacy repositories. Patient profiles, intake surveys, screening questionnaires, consent documentation, and marketing funnel interactions lived in isolated operational systems without uniform schemas. That dispersion made it difficult for recruitment specialists to evaluate study feasibility across active trial sites and geographical boundaries.

Assessing patient availability previously required recruitment staff to submit detailed requests to technical database administrators. Engineers manually translated study criteria into custom database queries, extracted candidate records, and validated results against protocol constraints. Each revision to demographic or clinical parameters restarted this manual extraction cycle from the beginning.

This dependency on technical handoffs introduced significant operational delays during study planning phases. Complex cohort discovery tasks involving multiple diagnostic filters, geographic boundaries, and consent criteria frequently required days or weeks of iterative back-and-forth work. Recruitment planners needed an architecture that separated operational transactional workloads from analytical discovery without bypassing organizational data governance rules.

02Standardized recruitment data foundation on storage

Thermo Fisher Scientific addressed these operational bottlenecks by building a centralized patient recruitment data foundation directly on AWS. The data foundation ingests raw inputs from patient profiles, questionnaires, operational workflows, and marketing campaigns into standardized analytical schemas. Curating these sources creates reusable assets that serve downstream analytics applications without altering upstream transactional source systems.

The architecture establishes an explicit separation of concerns between operational databases and downstream analytics workloads. Source systems continue processing active clinical registrations and administrative workflows without performance degradation from analytical queries. Curated datasets provide uniform definitions of recruitment milestones, allowing multiple analytical tools to reference verified patient cohorts across active clinical trials.

Standardizing recruitment data eliminated the need for engineering teams to build custom extraction pipelines for every new reporting request. The unified repository allows technical teams to maintain consistent governance, access permissions, and regulatory compliance standards across all clinical datasets. Business users receive validated, dependable recruitment metrics across every study site from a single managed data environment.

03Central Insights Hub operational recruitment dashboards

To provide end-to-end visibility across clinical trials, Thermo Fisher Scientific developed the Central Insights Hub using open-source technologies. The custom interface acts as a centralized reporting platform where operational teams monitor participant progression across clinical studies. Dashboards track participants from initial outreach through pre-screening, site referral, consent, trial enrollment, and final study randomization milestones.

The platform aggregates operational data to reveal recruitment velocity, site-level engagement, and geographical performance trends across countries. Operational teams can review participant disqualification trends, evaluate recruitment costs across specific marketing channels, and track demographic representations across participating trial sites. Centralizing these metrics enables recruitment leads to identify trial bottlenecks and allocate operational resources where participant engagement lags.

Interactive visualizations allow clinical trial managers to compare performance metrics across disparate clinical facilities in real time. Teams can identify underperforming regions early in the trial lifecycle and adjust operational workflows before enrollment targets fall behind schedule. Central Insights Hub establishes an empirical baseline that guides recruitment decisions across complex, multi-site global research programs.

04Patient Match AI natural language discovery

Thermo Fisher Scientific built Patient Match AI as a proprietary internal tool to streamline patient identification and feasibility assessments. The system allows non-technical recruitment staff to query clinical populations using standard natural-language prompts instead of writing complex database code. Users start by assessing overall population counts for specific clinical conditions and progressively narrow results using conversational refinements.

The tool structures search interactions through a defined operational sequence moving from count estimation to refinement, targeted list generation, and final export. Users refine cohorts by layering criteria such as patient age, geographic location, diagnosis history, previous therapies, and verified contactability attributes. Recruitment teams can adjust study parameters dynamically and observe instant changes in candidate population totals.

This conversational search model compresses cohort discovery timelines from several weeks of manual engineering iterations down to minutes. The tool presents aggregate statistics and demographic visualizations so teams can evaluate cohort composition before requesting access to identifiable patient records. Strict governance controls ensure that patient privacy, consent verifications, and personally identifiable information protections remain enforced throughout the process.

05Cloud architecture and launch readiness support

The underlying cloud infrastructure combines managed storage, orchestration, and serverless analytics services on AWS. Amazon Simple Storage Service provides scalable object storage for recruitment data, while AWS Glue manages data transformations and automated metadata cataloging. AWS Step Functions orchestrates multi-stage processing workflows, and Amazon Athena executes analytical queries across datasets stored as Apache Iceberg tables on Amazon S3.

Adopting Apache Iceberg table formats allows the platform to run complex cohort evaluations across large volumes of patient records with low latency. Decoupling analytical query engines from operational transactional applications protects clinical production systems from computational strain during intensive searches. This design provides horizontal scalability as patient data volumes and concurrent feasibility queries increase over time.

During the production deployment phase, Thermo Fisher Scientific engaged AWS Countdown Premium to validate architectural readiness and mitigate operational risks. Cloud specialists assisted the engineering team with architectural reviews, operational runbooks, and launch monitoring across critical deployment milestones. This operational review ensured the platform met strict resilience, performance, and compliance requirements before supporting active clinical trial programs.